The Living Therapeutics Initiative includes a new facility to be located on the Mission Bay campus dedicated to producing cellular products for testing in patients.

Thermo Fisher will build and operate a 44,000-square-foot, state-of-the-art cell therapy development, manufacturing and collaboration center in leased space on UCSF’s Mission Bay campus, which includes biomedical research facilities and hospitals. The site will offer clinical and commercial cGMP (current Good Manufacturing Practice) cell therapy manufacturing services, along with associated technology development support, to UCSF and other partners. 

LTI Facility UCSFExpected to open in late 2022, the facility will also serve as a central location where Thermo Fisher customers and UCSF researchers will have access to Thermo Fisher’s broad portfolio of Cell Therapy Systems (CTS) reagents, consumables, and fit-for-purpose instrumentation and compliant software. The CTS product portfolio is designed to work together, and seamlessly transition from research to clinical manufacturing to address cell therapy production workflow challenges.